|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02327 MEILLEUREHEALTH
Nominal 
0.300 +0.010 (+3.448%) | 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Turnover | 129,304 | 7.849% | 119,894 | 253,031 | 265,135 | 234,779 |
| Cost of Sales | (51,214) | -3.612% | (53,133) | (152,102) | (153,884) | (162,947) |
| Gross Profit | 78,090 | 16.969% | 66,761 | 100,929 | 111,251 | 71,832 |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | 20,086 | 47.898% | 13,581 | 15,190 | (16,869) | 21,990 | |
| Change in FV & Impairment on Others | (3,962) | -- | -- | -- | -- | (33,017) | |
| Profit / (Loss) on Disposal | 3,900 | -58.665% | 9,435 | 14,844 | 45,785 | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (4,353) | -70.536% | (14,774) | (11,068) | (4,201) | (21,763) | |
| Profit / (Loss) before Taxation | 52,983 | 108.718% | 25,385 | 85,704 | 103,587 | (5,344) | |
| Taxation | (14,493) | 90.572% | (7,605) | (25,248) | (18,521) | (17,666) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 2,340 | 5471.429% | 42 | (133) | (1,627) | 2,836 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 40,830 | 129.099% | 17,822 | 60,323 | 83,439 | (20,174) | |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Net Finance Costs / (Income) | (7,416) | -52.031% | (15,460) | (4,064) | 5,445 | 8,141 |
| Depreciation & Amortisation | 2,639 | -31.490% | 3,852 | 3,576 | 7,909 | 6,192 |
| Directors' Emoluments | 1,693 | -35.233% | 2,614 | 3,938 | 4,566 | 2,512 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | 1.000 | 132.558% | 0.430 | 1.420 | 1.950 | -0.480 |
| DPS (cts) | 0.400 | -- | 1.600 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | 40.000% | -- | 372.093% | -- | -- | -- |
| Cash flow per share ($) | (0.033) | -- | 0.011 | (0.020) | 0.017 | 0.006 |
| NBV per share ($) | 0.306 | -- | 0.323 | 0.339 | 0.328 | 0.295 |
| Remarks: | Real time quote last updated: 24/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD 8,465,000 |
| %Change | -53.387% |
| EPS / (LPS) | HKD 0.002 |
| NBV Per Share ($) | HKD 0.298 |